Biotin anti-mouse CD8a Antibody

Pricing & Availability
Clone
53-6.7 (See other available formats)
Regulatory Status
RUO
Other Names
T8, Lyt2, Ly-2
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
53-6dot7_Biotin_041106
C57BL/6 mouse splenocytes were stained with biotinylated CD8 (clone 53-6.7) (filled histogram) or rat IgG2a, κ isotype control (open histogram), followed by Sav-PE.
  • 53-6dot7_Biotin_041106
    C57BL/6 mouse splenocytes were stained with biotinylated CD8 (clone 53-6.7) (filled histogram) or rat IgG2a, κ isotype control (open histogram), followed by Sav-PE.
Cat # Size Price Quantity Check Availability Save
100703 50 µg $35.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100704 500 µg $80.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.

Product Details
Technical data sheet

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
Application

FC - Quality tested
IHC - Reported in the literature, not verified in house

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, and immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Application References

(PubMed link indicates BioLegend citation)
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
Product Citations
  1. Duarte D, et al. 2018. Cell Stem Cell. 22:64. PubMed
  2. Hirota K et al. 2018. Immunity. 48(6):1220-1232 . PubMed
  3. Sevin M, et al. 2018. Nat Commun. 9:1431. PubMed
  4. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
  5. Giambra V et al. 2018. Cell stem cell. 23(5):714-726 . PubMed
  6. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  7. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  8. Macal M et al. 2018. Immunity. 48(4):730-744 . PubMed
  9. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  10. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  11. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  12. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  13. Zhang Z, et al. 2019. Haematologica. 4.339583333. PubMed
  14. Matsumura T et al. 2019. Cell Rep. 27(2):561-571 . PubMed
  15. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  16. Xu L et al. 2017. Immunity. 47(3):538-551 . PubMed
  17. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  18. Miyazaki M et al. 2017. Immunity. 46(5):818-834 . PubMed
  19. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  20. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  21. Akkaya B, et al. 2017. J Immunol Methods. 441:67. PubMed
  22. Zhu C, et al. 2018. Sci Rep. 5.113194444. PubMed
  23. Wang L, et al. 2019. Cell Rep. 29:1848. PubMed
  24. Khaw YM, et al. 2020. J Neuroinflammation. 17:49. PubMed
  25. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  26. Au-Yeung BB, et al. 2017. J Immunol. 198:2445. PubMed
  27. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  28. Ji Y, et al. 2019. Nat Immunol. 1.303472222. PubMed
  29. Hu J, et al. 2019. Am J Transl Res. 3.043055556. PubMed
  30. He M, et al. 2020. Cell Metabolism. 31(3):580-591. PubMed
  31. He J, et al. 2020. Cell Reports. 29(9):2718-2730.e6.. PubMed
  32. Kaya B, et al. 2020. Cell Reports. 32(5):107979. PubMed
  33. Frohner IE, et al. 2020. Cell Rep. 30:3171. PubMed
  34. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  35. Andersen L, et al. 2020. Cell Reports. 29(13):4447-4459.e6.. PubMed
  36. Gravano D, et al. 2010. PLoS One. 5:e13528. PubMed
  37. Davidson M, et al. 2013. PLoS One. 8:76258. PubMed
  38. Nagaoka M, et al. 2014. J Immunol. 193:2812. PubMed
  39. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  40. Holm J, et al. 2015. PLoS One. 10:125495. PubMed
  41. Elsner R, et al. 2015. PLoS Pathog. 10: 1004976. PubMed
  42. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  43. Donley D, et al. 2016. PLoS One. 11: 0162404. PubMed
  44. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  45. Van de Velde L, et al. 2016. Cell Rep. 17:2247-2258. PubMed
  46. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  47. Xu X, et al. 2020. J Cell Biol. 219:00:00. PubMed
  48. Köchl R, et al. 2020. Elife. 9:00. PubMed
  49. Haniuda K, et al. 2020. Cell Rep. 33:108333. PubMed
  50. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  51. Khiew SH, et al. 2020. J Clin Invest. 130:3453. PubMed
  52. Mendes A, et al. 2021. Life Sci Alliance. 4:00. PubMed
  53. Hutter K, et al. 2020. Molecular Cell. 78(5):876-889.e6. PubMed
  54. Wang F, et al. 2021. Cell. 184(2):422-440.e17. PubMed
  55. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  56. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  57. Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed
  58. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  59. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  60. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  61. Kawakami R, et al. 2021. Immunity. 54(5):947-961.e8. PubMed
  62. Young K, et al. 2021. Cell Stem Cell. . PubMed
  63. Riedel SS, et al. 2021. Molecular Cell. 81(11):2332-2348.e9. PubMed
  64. Iturri L, et al. 2021. Immunity. . PubMed
RRID
AB_312742 (BioLegend Cat. No. 100703)
AB_312743 (BioLegend Cat. No. 100704)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8a on UniProt.org

Related FAQs

How many biotin molecules are per antibody structure?
We don't routinely measure the number of biotins with our antibody products but the number of biotin molecules range from 3-6 molecules per antibody.
Go To Top Version: 2    Revision Date: 01/21/2014

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account